China’s 80%‑Efficient Stem Cell Breakthrough Signals a New Era in Regenerative Parkinson’s Care
Chinese researchers have developed a stem cell–based therapy for Parkinson’s disease that achieves an unprecedented 80% conversion of stem cells into dopamine-producing neurons, far above earlier international benchmarks. In early clinical use, six patients have shown rapid motor improvement and sustained dopamine signaling on brain imaging, raising the possibility of true functional recovery rather than temporary symptom control.